ABSTRACT
Toxoplasma gondii is an orally acquired pathogen that induces strong IFN-γ based immunity conferring protection but that can also be the cause of immunopathology. The response in mice is driven in part by well-characterized MyD88-dependent signaling pathways. Here we focus on induction of less well understood immune responses that do not involve this Toll-like receptor (TLR)/IL-1 family receptor adaptor molecule, in particular as they occur in the intestinal mucosa. Using eYFP-IL-12p40 reporter mice on an MyD88-/- background, we identified dendritic cells, macrophages, and neutrophils as cellular sources of MyD88-independent IL-12 after peroral T. gondii infection. Infection-induced IL-12 was lower in the absence of MyD88, but was still clearly above noninfected levels. Overall, this carried through to the IFN-γ response, which while generally decreased was still remarkably robust in the absence of MyD88. In the latter mice, IL-12 was strictly required to induce type I immunity. Type 1 and type 3 innate lymphoid cells (ILC), CD4+ T cells, and CD8+ T cells each contributed to the IFN-γ pool. We report that ILC3 were expanded in infected MyD88-/- mice relative to their MyD88+/+ counterparts, suggesting a compensatory response triggered by loss of MyD88. Furthermore, bacterial flagellin and Toxoplasma specific CD4+ T cell populations in the lamina propria expanded in response to infection in both WT and KO mice. Finally, we show that My88-independent IL-12 and T cell mediated IFN-γ production require the presence of the intestinal microbiota. Our results identify MyD88-independent intestinal immune pathways induced by T. gondii including myeloid cell derived IL-12 production, downstream type I immunity and IFN-γ production by ILC1, ILC3, and T lymphocytes. Collectively, our data reveal an underlying network of immune responses that do not involve signaling through MyD88.
Subject(s)
CD4-Positive T-Lymphocytes/immunology , Gastrointestinal Microbiome/immunology , Immunity, Mucosal/immunology , Interleukin-12 Subunit p40/immunology , Toxoplasmosis, Animal/immunology , Animals , Intestinal Mucosa/immunology , Mice , Mice, Knockout , Myeloid Differentiation Factor 88/deficiency , Myeloid Differentiation Factor 88/immunology , Signal Transduction/immunology , Toll-Like Receptors/deficiency , Toll-Like Receptors/immunology , Toxoplasma/immunologyABSTRACT
The apicomplexan Toxoplasma gondii induces strong protective immunity dependent upon recognition by Toll-like receptors (TLR)11 and 12 operating in conjunction with MyD88 in the murine host. However, TLR11 and 12 proteins are not present in humans, inspiring us to investigate MyD88-independent pathways of resistance. Using bicistronic IL-12-YFP reporter mice on MyD88+/+ and MyD88-/- genetic backgrounds, we show that CD11c+MHCII+F4/80- dendritic cells, F4/80+ macrophages, and Ly6G+ neutrophils were the dominant cellular sources of IL-12 in both wild type and MyD88 deficient mice after parasite challenge. Parasite dense granule protein GRA24 induces p38 MAPK activation and subsequent IL-12 production in host macrophages. We show that Toxoplasma triggers an early and late p38 MAPK phosphorylation response in MyD88+/+ and MyD88-/- bone marrow-derived macrophages. Using the uracil auxotrophic Type I T. gondii strain cps1-1, we demonstrate that the late response does not require active parasite proliferation, but strictly depends upon GRA24. By i. p. inoculation with cps1-1 and cps1-1:Δgra24, we identified unique subsets of chemokines and cytokines that were up and downregulated by GRA24. Finally, we demonstrate that cps1-1 triggers a strong host-protective GRA24-dependent Th1 response in the absence of MyD88. Our data identify GRA24 as a major mediator of p38 MAPK activation, IL-12 induction and protective immunity that operates independently of the TLR/MyD88 cascade.
Subject(s)
Interleukin-12/immunology , MAP Kinase Signaling System/immunology , Macrophages/immunology , Myeloid Differentiation Factor 88/immunology , Protozoan Proteins/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , p38 Mitogen-Activated Protein Kinases/immunology , Animals , Enzyme Activation/genetics , Enzyme Activation/immunology , Interleukin-12/genetics , MAP Kinase Signaling System/genetics , Macrophages/parasitology , Macrophages/pathology , Mice , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Protozoan Proteins/genetics , Toxoplasma/genetics , Toxoplasmosis/genetics , Toxoplasmosis/pathology , p38 Mitogen-Activated Protein Kinases/geneticsABSTRACT
Signalling by IFN-y and CD40 is known to trigger anti-microbial activity in macrophages infected with Toxoplasma gondii, but their effects on infected neurons are less well known. Here, we compared how stimulation with IFN-y and an agonistic anti-CD40 mAb impacts infection and cyst formation in the mouse neuroblastoma cell line Neuro-2a relative to bone marrow-derived macrophages. Both IFN-y and CD40 mAb decreased cyst emergence in Neuro-2a cells. In macrophages, these stimuli decreased infection, but had no impact on infection in the neuroblastoma cell line. Resistance to killing in Neuro-2a cells may explain why neurons preferentially harbour parasites during chronic infection in the brain.
Subject(s)
CD40 Antigens , Interferon-gamma , Toxoplasma , Animals , CD40 Antigens/metabolism , Cell Line, Tumor , Interferon-gamma/metabolism , Mice , Neuroblastoma , Toxoplasma/pathogenicityABSTRACT
BACKGROUND: Toxoplasma gondii is a globally distributed protozoan parasite that establishes life-long asymptomatic infection in humans, often emerging as a life-threatening opportunistic pathogen during immunodeficiency. As an intracellular microbe, Toxoplasma establishes an intimate relationship with its host cell from the outset of infection. Macrophages are targets of infection and they are important in early innate immunity and possibly parasite dissemination throughout the host. Here, we employ an RNA-sequencing approach to identify host and parasite transcriptional responses during infection of mouse bone marrow-derived macrophages (BMDM). We incorporated into our analysis infection with the high virulence Type I RH strain and the low virulence Type II strain PTG. Because the well-known TLR-MyD88 signaling axis is likely of less importance in humans, we examined transcriptional responses in both MyD88+/+ and MyD88-/- BMDM. Long noncoding (lnc) RNA molecules are emerging as key regulators in infection and immunity, and were, therefore, included in our analysis. RESULTS: We found significantly more host genes were differentially expressed in response to the highly virulent RH strain rather than with the less virulent PTG strain (335 versus 74 protein coding genes for RH and PTG, respectively). Enriched in these protein coding genes were subsets associated with the immune response as well as cell adhesion and migration. We identified 249 and 83 non-coding RNAs as differentially expressed during infection with RH and PTG strains, respectively. Although the majority of these are of unknown function, one conserved lncRNA termed mir17hg encodes the mir17 microRNA gene cluster that has been implicated in down-regulating host cell apoptosis during T. gondii infection. Only a minimal number of transcripts were differentially expressed between MyD88 knockout and wild type cells. However, several immune genes were among the differences. While transcripts for parasite secretory proteins were amongst the most highly expressed T. gondii genes during infection, no differentially expressed parasite genes were identified when comparing infection in MyD88 knockout and wild type host BMDM. CONCLUSIONS: The large dataset presented here lays the groundwork for continued studies on both the MyD88-independent immune response and the function of lncRNAs during Toxoplasma gondii infection.
Subject(s)
Toxoplasma , Toxoplasmosis , Animals , Humans , Macrophages , Mice , Myeloid Differentiation Factor 88/genetics , Toxoplasma/genetics , Toxoplasmosis/genetics , TranscriptomeABSTRACT
The function of mucosal dendritic cell (DC) subsets in immunity and inflammation is not well understood. In this study, we define four DC subsets present within the lamina propria and mesenteric lymph node compartments based on expression of CD103 and CD11b. Using IL-12p40 YFP (Yet40) reporter mice, we show that CD103(+)CD11b(-) mucosal DCs are primary in vivo sources of IL-12p40; we also identified CD103(-)CD11b(-) mucosal DCs as a novel population producing this cytokine. Infection was preferentially found in CD11b(+) DCs that were negative for CD103. Lamina propria DCs containing parasites were negative for IL-12p40. Instead, production of the cytokine was strictly a property of noninfected cells. We also show that vitamin A metabolism, as measured by ALDH activity, was preferentially found in CD103(+)CD11b(+) DC and was strongly downregulated in all mucosal DC subsets during infection. Finally, overall apoptosis of lamina propria DC subsets was increased during infection. Combined, these results highlight the ability of intestinal Toxoplasma infection to alter mucosal DC activity at both the whole population level and at the level of individual subsets.
Subject(s)
Dendritic Cells/immunology , Intestinal Mucosa/immunology , Lymph Nodes/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Aldehyde Dehydrogenase 1 Family , Animals , Antigens, CD/biosynthesis , Apoptosis/immunology , Bacterial Proteins/genetics , CD11b Antigen/biosynthesis , Dendritic Cells/parasitology , Down-Regulation , Female , Integrin alpha Chains/biosynthesis , Interferon Regulatory Factors/immunology , Interleukin-12 Subunit p40/biosynthesis , Interleukin-12 Subunit p40/genetics , Intestinal Mucosa/cytology , Intestinal Mucosa/parasitology , Isoenzymes/metabolism , Luminescent Proteins/genetics , Lymph Nodes/cytology , Mice , Mice, Inbred C57BL , Monocytes/metabolism , Retinal Dehydrogenase/metabolism , Th1 Cells/immunology , Toxoplasmosis/parasitology , Tretinoin/metabolism , Vitamin A/metabolismABSTRACT
Beta-catenin signaling has recently been tied to the emergence of tolerogenic dendritic cells (DCs). In this article, we demonstrate a novel role for beta-catenin in directing DC subset development through IFN regulatory factor 8 (IRF8) activation. We found that splenic DC precursors express beta-catenin, and DCs from mice with CD11c-specific constitutive beta-catenin activation upregulated IRF8 through targeting of the Irf8 promoter, leading to in vivo expansion of IRF8-dependent CD8a+, plasmacytoid, and CD103+ CD11b2 DCs. beta-cateninstabilized CD8a+ DCs secreted elevated IL-12 upon in vitro microbial stimulation, and pharmacological beta-catenin inhibition blocked this response in wild-type cells. Upon infections with Toxoplasma gondii and vaccinia virus, mice with stabilized DC beta-catenin displayed abnormally high Th1 and CD8+ T lymphocyte responses, respectively. Collectively, these results reveal a novel and unexpected function for beta-catenin in programming DC differentiation toward subsets that orchestrate proinflammatory immunity to infection.
Subject(s)
Dendritic Cells/cytology , Dendritic Cells/immunology , Inflammation/immunology , Interferon Regulatory Factors/genetics , beta Catenin/immunology , Animals , Antigens, CD/immunology , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , CD11c Antigen/immunology , CD8 Antigens/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Differentiation/immunology , Enzyme Activation , Female , Integrin alpha Chains/immunology , Interferon Regulatory Factors/immunology , Interleukin-12/biosynthesis , Interleukin-12/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Parasite Load , Promoter Regions, Genetic , Pyrimidinones/pharmacology , Receptors, Cell Surface/genetics , Signal Transduction/immunology , Spleen/cytology , Spleen/immunology , Th1 Cells/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Vaccinia/immunology , Vaccinia virus/immunology , beta Catenin/antagonists & inhibitors , beta Catenin/biosynthesisABSTRACT
Toll-like receptors (TLRs) have emerged as a major receptor family involved in non-self recognition. They have a vital role in triggering innate immunity and orchestrate the acquired immune response during bacterial and viral infection. However, the role of TLRs during infection with protozoan pathogens is less clear. Nevertheless, our understanding of how these parasitic microorganisms engage the host TLR signalling system has now entered a phase of rapid expansion. This Review describes recent insights into how parasitic protozoans are sensed by TLR molecules, and how the TLR system itself can be targeted by these microbial pathogens for their own survival.
Subject(s)
Eukaryota/immunology , Protozoan Infections/immunology , Toll-Like Receptors/physiology , Animals , Host-Parasite Interactions , Mice , Signal TransductionABSTRACT
Chemokines and their receptors play a critical role in orchestrating immunity to microbial pathogens, including the orally acquired Th1-inducing protozoan parasite Toxoplasma gondii. Chemokine receptor CXCR3 is associated with Th1 responses, and here we use bicistronic CXCR3-eGFP knock-in reporter mice to demonstrate upregulation of this chemokine receptor on CD4⺠and CD8⺠T lymphocytes during Toxoplasma infection. We show a critical role for CXCR3 in resistance to the parasite in the intestinal mucosa. Absence of the receptor in Cxcr3â»/â» mice resulted in selective loss of ability to control T. gondii specifically in the lamina propria compartment. CD4⺠T cells were impaired both in their recruitment to the intestinal lamina propria and in their ability to secrete IFN-γ upon stimulation. Local recruitment of CD11bâºLy6C/G⺠inflammatory monocytes, recently reported to be major anti-Toxoplasma effectors in the intestine, was not impacted by loss of CXCR3. However, inflammatory monocyte activation status, as measured by dual production of TNF-α and IL-12, was severely impaired in Cxcr3â»/â» mice. Strikingly, adoptive transfer of wild-type but not Ifnγâ»/â» CD4⺠T lymphocytes into Cxcr3â»/â» animals prior to infection corrected the defect in inflammatory macrophage activation, simultaneously reversing the susceptibility phenotype of the knockout animals. Our results establish a central role for CXCR3 in coordinating innate and adaptive immunity, ensuring generation of Th1 effectors and their trafficking to the frontline of infection to program microbial killing by inflammatory monocytes.
Subject(s)
Immunity, Cellular , Immunity, Innate , Intestinal Diseases/immunology , Monocytes/immunology , Receptors, CXCR3/immunology , Th1 Cells/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Interferon-gamma/genetics , Interferon-gamma/immunology , Intestinal Diseases/genetics , Intestinal Diseases/pathology , Mice , Mice, Knockout , Monocytes/pathology , Receptors, CXCR3/genetics , Th1 Cells/pathology , Toxoplasmosis/genetics , Toxoplasmosis/pathologyABSTRACT
Toxoplasma gondii is an obligate intracellular protozoan pathogen that traffics to the central nervous system (CNS) following invasion of its host. In the CNS, T. gondii undergoes transformation from a rapidly dividing tachyzoite to a long-lived, slow-dividing bradyzoite contained within cysts. The role of extracellular adenosine in T. gondii pathogenesis has not been previously investigated. T. gondii uses host purines such as adenosine for its energy needs, as it is unable to make its own. Here, we show that CD73(-/-) mice, which lack the ability to generate extracellular adenosine, are protected from T. gondii chronic infection, with significantly fewer cysts and reduced susceptibility to reactivation of infection in the CNS independent of host effector function. Parasite dissemination to the brain was unimpaired in CD73(-/-) hosts, suggesting that the reduced cyst number is due to impaired parasite differentiation in the CNS. Confirming this, T. gondii tachyzoites formed fewer cysts following alkaline pH stress in astrocytes isolated from CD73(-/-) mice compared with wild type, and in fibroblasts treated with a CD73 inhibitor. Cyst formation was rescued in CD73(-/-) astrocytes supplemented with adenosine, but not with adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine. Furthermore, mice lacking adenosine receptors had no defect in cyst formation. Based on these findings, we conclude that CD73 expression promotes Toxoplasma bradyzoite differentiation and cyst formation by a mechanism dependent on the generation of adenosine, but independent of adenosine receptor signaling. Overall, these findings suggest that modulators of extracellular adenosine may be used to develop therapies aimed at defending against human toxoplasmosis.
Subject(s)
Adenosine/metabolism , Central Nervous System/parasitology , Cysts/parasitology , Life Cycle Stages/physiology , Toxoplasma/physiology , Toxoplasmosis/genetics , 5'-Nucleotidase/genetics , Adenosine/deficiency , Adenosine/genetics , Analysis of Variance , Animals , DNA Primers/genetics , Dexamethasone , Female , Flow Cytometry , Kinetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Fluorescence , Polymerase Chain Reaction , Toxoplasmosis/prevention & controlABSTRACT
IL-12-mediated type 1 inflammation confers host protection against the parasitic protozoan Toxoplasma gondii. However, production of IFN-γ, another type 1 inflammatory cytokine, also drives lethality from excessive injury to the intestinal epithelium. As mechanisms that restore epithelial barrier function following infection remain poorly understood, this study investigated the role of trefoil factor 2 (TFF2), a well-established regulator of mucosal tissue repair. Paradoxically, TFF2 antagonized IL-12 release from dendritic cells (DCs) and macrophages, which protected TFF2-deficient (TFF2(-/-)) mice from T. gondii pathogenesis. Dysregulated intestinal homeostasis in naive TFF2(-/-) mice correlated with increased IL-12/23p40 levels and enhanced T cell recruitment at baseline. Infected TFF2(-/-) mice displayed low rates of parasite replication and reduced gut immunopathology, whereas wild-type (WT) mice experienced disseminated infection and lethal ileitis. p38 MAPK activation and IL-12p70 production was more robust from TFF2(-/-)CD8+ DC compared with WT CD8+ DC and treatment of WT DC with rTFF2 suppressed TLR-induced IL-12/23p40 production. Neutralization of IFN-γ and IL-12 in TFF2(-/-) animals abrogated resistance shown by enhanced parasite replication and infection-induced morbidity. Hence, TFF2 regulated intestinal barrier function and type 1 cytokine release from myeloid phagocytes, which dictated the outcome of oral T. gondii infection in mice.
Subject(s)
Down-Regulation/immunology , Mucins/physiology , Muscle Proteins/physiology , Peptides/physiology , Toxoplasma/immunology , Toxoplasmosis/immunology , Toxoplasmosis/parasitology , Animals , Cytokines/antagonists & inhibitors , Cytokines/metabolism , Disease Models, Animal , Down-Regulation/genetics , Immunity, Cellular/genetics , Inflammation/immunology , Inflammation/parasitology , Inflammation/pathology , Intestinal Mucosa/immunology , Intestinal Mucosa/parasitology , Intestinal Mucosa/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mucins/deficiency , Muscle Proteins/deficiency , Peptides/deficiency , Phagocytosis/genetics , Phagocytosis/immunology , Toxoplasma/genetics , Toxoplasmosis/pathology , Trefoil Factor-2ABSTRACT
The ROP16 kinase of Toxoplasma gondii is injected into the host cell cytosol where it activates signal transducer and activator of transcription (STAT)-3 and STAT6. Here, we generated a ROP16 deletion mutant on a Type I parasite strain background, as well as a control complementation mutant with restored ROP16 expression. We investigated the biological role of the ROP16 molecule during T. gondii infection. Infection of mouse bone marrow-derived macrophages with rop16-deleted (ΔROP16) parasites resulted in increased amounts of IL-12p40 production relative to the ROP16-positive RH parental strain. High level IL-12p40 production in ΔROP16 infection was dependent on the host cell adaptor molecule MyD88, but surprisingly was independent of any previously recognized T. gondii triggered pathway linking to MyD88 (TLR2, TLR4, TLR9, TLR11, IL-1ß and IL-18). In addition, ROP16 was found to mediate the suppressive effects of Toxoplasma on LPS-induced cytokine synthesis in macrophages and on IFN-γ-induced nitric oxide production by astrocytes and microglial cells. Furthermore, ROP16 triggered synthesis of host cell arginase-1 in a STAT6-dependent manner. In fibroblasts and macrophages, failure to induce arginase-1 by ΔROP16 tachyzoites resulted in resistance to starvation conditions of limiting arginine, an essential amino acid for replication and virulence of this parasite. ΔROP16 tachyzoites that failed to induce host cell arginase-1 displayed increased replication and dissemination during in vivo infection. We conclude that encounter between Toxoplasma ROP16 and the host cell STAT signaling cascade has pleiotropic downstream effects that act in multiple and complex ways to direct the course of infection.
Subject(s)
Arginase/metabolism , Cytokines/immunology , Protein-Tyrosine Kinases/metabolism , Protozoan Proteins/metabolism , STAT3 Transcription Factor/metabolism , STAT6 Transcription Factor/metabolism , Toxoplasma/pathogenicity , Animals , Arginase/antagonists & inhibitors , Arginase/genetics , Cells, Cultured , Female , Gene Deletion , Gene Knockout Techniques , Interleukin-12 Subunit p40/immunology , Janus Kinase 2/genetics , Janus Kinase 2/metabolism , Macrophages/immunology , Mice , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/metabolism , Phosphorylation , Plasmids , Protein-Tyrosine Kinases/genetics , Protozoan Proteins/genetics , STAT3 Transcription Factor/genetics , STAT6 Transcription Factor/genetics , Signal Transduction , Toxoplasma/enzymology , Toxoplasma/geneticsABSTRACT
The intracellular protozoan Toxoplasma gondii is well known for its skill at invading and living within host cells. New discoveries are now also revealing the astounding ability of the parasite to inject effector proteins into the cytoplasm to seize control of the host cell. This review summarizes recent advances in our understanding of one such secretory protein called ROP16. This molecule is released from rhoptries into the host cell during invasion. The ROP16 molecule acts as a kinase, directly activating both signal transducer and activator of transcription 3 (STAT3) and STAT6 signaling pathways. In macrophages, an important and preferential target cell of parasite infection, the injection of ROP16 has multiple consequences, including downregulation of proinflammatory cytokine signaling and macrophage deviation to an alternatively activated phenotype.
Subject(s)
Janus Kinases/metabolism , STAT Transcription Factors/metabolism , Signal Transduction/physiology , Toxoplasma/physiology , AnimalsABSTRACT
Neutrophils have recently been shown to release DNA-based extracellular traps that contribute to microbicidal killing and have also been implicated in autoimmunity. The role of neutrophil extracellular trap (NET) formation in the host response to nonbacterial pathogens has received much less attention. Here, we show that the protozoan pathogen Toxoplasma gondii elicits the production of NETs from human and mouse neutrophils. Tachyzoites of each of the three major parasite strain types were efficiently entrapped within NETs, resulting in decreased parasite viability. We also show that Toxoplasma activates a MEK-extracellular signal-regulated kinase (ERK) pathway in neutrophils and that the inhibition of this pathway leads to decreased NET formation. To determine if Toxoplasma induced NET formation in vivo, we employed a mouse intranasal infection model. We found that the administration of tachyzoites by this route induced a rapid tissue recruitment of neutrophils with evidence of extracellular DNA release. Taken together, these data indicate a role for NETs in the host innate response to protozoan infection. We propose that NET formation limits infection by direct microbicidal effects on Toxoplasma as well as by interfering with the ability of the parasite to invade target host cells.
Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , Extracellular Space/immunology , Neutrophils/metabolism , Neutrophils/parasitology , Toxoplasma/physiology , Toxoplasmosis, Animal/immunology , Animals , Cell Line , Female , Gene Expression Regulation/immunology , Humans , Mice , Mice, Inbred C57BL , Neutrophil Activation , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolismABSTRACT
Oral infection of certain inbred mouse strains with the protozoan Toxoplasma gondii triggers inflammatory pathology resembling lesions seen during human inflammatory bowel disease, in particular Crohn's disease (CD). Damage triggered by the parasite is largely localized to the distal portion of the small intestine, and as such is one of only a few models for ileal inflammation. This is important because ileal involvement is a characteristic of CD in over two-thirds of patients. The disease induced by Toxoplasma is mediated by Th1 cells and the cytokines tumor necrosis factor-α and interferon-γ. Inflammation is dependent upon IL-23, also identified by genome-wide association studies as a risk factor in CD. Development of lesions is concomitant with emergence of E. coli that display enhanced adhesion to the intestinal epithelium and subepithelial translocation. Furthermore, depletion of gut flora renders mice resistant to Toxoplasma-triggered ileitis. Recent findings suggest complex CCR2-dependent interactions between lamina propria T cells and intraepithelial lymphocytes in fueling proinflammatory pathology in the intestine. The advantage of the Toxoplasma model is that disease develops rapidly (within 7-10 days of infection) and can be induced in immunodeficient mice by adoptive transfer of mucosal T cells from infected donors. We propose that Toxoplasma acts as a trigger setting into motion a series of events culminating in loss of tolerance in the intestine and emergence of pathogenic T cell effectors. The Toxoplasma trigger model is providing new leaps in our understanding of immunity in the intestine.
Subject(s)
Disease Models, Animal , Ileitis/immunology , Inflammatory Bowel Diseases/immunology , Toxoplasma/immunology , Toxoplasmosis, Animal/immunology , Animals , Cytokines/immunology , Cytokines/metabolism , Humans , Ileitis/metabolism , Ileitis/parasitology , Inflammatory Bowel Diseases/metabolism , Mice , Models, Immunological , Receptors, CCR2/immunology , Receptors, CCR2/metabolism , Toxoplasmosis, Animal/metabolism , Toxoplasmosis, Animal/parasitologyABSTRACT
Neutrophils play a major role in the innate immune system and are normally considered to be short-lived effector cells that exert anti-microbial activity and sometimes immunopathology. Here, we show that these cells possess an additional function as professional antigen-presenting cells capable of priming a T(h)1- and T(h)17-acquired immune response. Using flow cytometry, fluorescence microscopy and western blotting, we show that mouse neutrophils express MHC class II and co-stimulatory molecules CD80 and CD86 after T-cell co-incubation. Neutrophils pulsed with ovalbumin (OVA) process and present peptide antigen to OVA-specific T cells in an MHC class II-dependent manner. Importantly, we demonstrate that neutrophils can prime antigen-specific T(h)1 and T(h)17 immune responses even without the addition of exogenous cytokines to cell cultures.
Subject(s)
Antigen-Presenting Cells/immunology , Cell Differentiation/immunology , Neutrophils/immunology , Th1 Cells/cytology , Th1 Cells/immunology , Th17 Cells/cytology , Th17 Cells/immunology , Animals , Antigens/immunology , Cell Line , Female , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Ovalbumin/immunologyABSTRACT
Toxoplasma gondii induces strong IFN-γ-based immunity. Innate lymphoid cells (ILC), in particular ILC1, are an important innate source of this protective cytokine during infection. Our objective was to determine how MyD88-dependent signaling influences ILC function during peroral compared with i.p. infection with T. gondii. MyD88 +/+ and MyD88 -/- mice were orally inoculated with ME49 cysts, and small intestinal lamina propria ILC were assessed using flow cytometry. We observed T-bet+ ILC1, retinoic acid-related orphan receptor γt+ ILC3, and a population of T-bet+retinoic acid-related orphan receptor γt+ double-positive ILC. In MyD88 -/- mice, IFN-γ-producing T-bet+ ILC1 frequencies were reduced compared with wild-type. Treatment of MyD88 -/- mice with an antibiotic mixture to deplete microflora reduced IFN-γ+ ILC1 frequencies. To examine ILC responses outside of the mucosal immune system, peritoneal exudate cells were collected from wild-type and knockout mice after i.p. inoculation with ME49 cysts. In this compartment, ILC were highly polarized to the ILC1 subset that increased significantly and became highly positive for IFN-γ over the course of infection. Increased ILC1 was associated with expression of the Ki67 cell proliferation marker, and the response was driven by IL-12p40. In the absence of MyD88, IFN-γ expression by ILC1 was not maintained, but proliferation remained normal. Collectively, these data reveal new aspects of ILC function that are influenced by location of infection and shaped further by MyD88-dependent signaling.
Subject(s)
Microbiota , Toxoplasmosis , Animals , Immunity, Innate , Lymphocytes , Mice , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , TretinoinABSTRACT
Macrophages infected with the opportunistic protozoan Toxoplasma gondii are unable to up-regulate many proinflammatory cytokine genes, including TNF (TNF-alpha), upon stimulation with LPS and other TLR ligands. In this study, we examined the influence of T. gondii on transcription factors associated with TNF-alpha transcription, as well as phosphorylation and acetylation of histone H3 at distal and proximal regions of the TNF-alpha promoter. During LPS stimulation, we found that Toxoplasma blocks nuclear accumulation of transcription factor c-Jun, but not that of cAMP response element-binding protein or NF-kappaB. However, chromatin immunoprecipitation studies revealed that binding of all of these transcription factors to the TNF promoter was decreased by T. gondii infection. Furthermore, the parasite blocked LPS-induced Ser(10) phosphorylation and Lys(9)/Lys(14) acetylation of histone H3 molecules associated with distal and proximal regions of the TNF-alpha promoter. Our results show that Toxoplasma inhibits TNF-alpha transcription by interfering with chromatin remodeling events required for transcriptional activation at the TNF promoter, revealing a new mechanism by which a eukaryotic pathogen incapacitates proinflammatory cytokine production during infection.
Subject(s)
Chromatin Assembly and Disassembly/immunology , Macrophage Activation/immunology , Toll-Like Receptors/physiology , Toxoplasma/immunology , Acetylation , Animals , Cells, Cultured , Chromatin Assembly and Disassembly/genetics , Cyclic AMP Response Element-Binding Protein/biosynthesis , Cyclic AMP Response Element-Binding Protein/metabolism , Female , Histones/antagonists & inhibitors , Histones/physiology , Humans , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/physiology , Lipopolysaccharides/pharmacology , Macrophage Activation/genetics , Macrophages/enzymology , Macrophages/immunology , Macrophages/parasitology , Mice , Mice, Inbred C57BL , Phosphorylation/immunology , Promoter Regions, Genetic/immunology , Protein Transport/genetics , Protein Transport/immunology , Proto-Oncogene Proteins c-jun/antagonists & inhibitors , Proto-Oncogene Proteins c-jun/metabolism , RNA Polymerase II/antagonists & inhibitors , RNA Polymerase II/metabolism , Toll-Like Receptors/antagonists & inhibitors , Transcription Factor RelA/biosynthesis , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Toxoplasma gondii is an intracellular pathogen notable for its ability to establish a stable host-parasite relationship amongst a wide range of host species and in a large percentage of the human population. Toll-like receptor signaling through MyD88 is a critical pathway in initiating defense against this opportunistic protozoan and may also be a mediator of pathology during immune dysfunction. Other MyD88 independent signaling pathways are also involved in the host-parasite interaction. These responses can be triggered by the parasite itself, but interactions with the intestinal microbiota add additional complexity during enteric infection.
Subject(s)
Toll-Like Receptors/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , Disease Models, Animal , Host-Parasite Interactions/immunology , Humans , Mice , Myeloid Differentiation Factor 88/immunology , Signal Transduction/immunologyABSTRACT
Plasmacytoid dendritic cells (pDCs) play a key role in the innate immune response to viral infection, due largely to their ability to produce large quantities of type I IFNs. These cells are also notable for their ability to differentiate into conventional dendritic cells after appropriate stimulation. Here, we show that a splenic population of murine CD11c(+) cells expressing pDC markers Gr-1, B220, and PDCA-1 is preferentially parasitized after infection with the virulent RH strain of Toxoplasma gondii. Although these markers are closely associated with pDCs, the population we identified was unusual because the cells express CD11b and higher than expected levels of CD11c. By adoptive transfer of CD45.1-positive cells into CD45.2 congenic mice, we show that CD11c(+)Gr-1(+) cells migrate from the peritoneal cavity to the spleen. During infection, these cells accumulate in the marginal zone region. Recruitment of infected CD11c(+)Gr-1(+) cells to the spleen is partially dependent upon signaling through chemokine receptor CCR2. Intracellular cytokine staining demonstrates that infected, but not noninfected, splenic CD11c(+)Gr-1(+) dendritic cells are suppressed in their ability to respond to ex vivo TLR stimulation. We hypothesize that Toxoplasma exploits pDCs as Trojan horses, targeting them for early infection, suppressing their cytokine effector function, and using them for dissemination within the host.
Subject(s)
Antigens, Surface/biosynthesis , Dendritic Cells/immunology , Dendritic Cells/parasitology , Toxoplasmosis/immunology , Toxoplasmosis/parasitology , Animals , Antigens, Surface/genetics , Biomarkers/metabolism , CD11c Antigen/biosynthesis , CD11c Antigen/genetics , Cells, Cultured , Dendritic Cells/metabolism , Female , Immunophenotyping , Interleukin-12/antagonists & inhibitors , Interleukin-12/biosynthesis , Mice , Mice, Congenic , Mice, Inbred C57BL , Mice, Knockout , Peritoneum/immunology , Peritoneum/parasitology , Peritoneum/pathology , Receptors, Chemokine/biosynthesis , Receptors, Chemokine/genetics , Toxoplasma/genetics , Toxoplasma/growth & development , Toxoplasma/immunology , Toxoplasmosis/metabolismABSTRACT
TLR adaptor MyD88 activation is important in host resistance to Toxoplasma gondii during i.p. infection, but the function of this signaling pathway during oral infection, in which mucosal immunity assumes a predominant role, has not been examined. In this study, we show that MyD88(-/-) mice fail to control the parasite and succumb within 2 wk of oral infection. Early during infection, T cell IFN-gamma production, recruitment of neutrophils and induction of p47 GTPase IGTP (Irgm3) in the intestinal mucosa were dependent upon functional MyD88. Unexpectedly, these responses were MyD88-independent later during acute infection. In particular, CD4(+) T cell IFN-gamma reached normal levels independently of MyD88, despite continued absence of IL-12 in these animals. The i.p. vaccination of MyD88(-/-) mice with an avirulent T. gondii uracil auxotroph elicited robust IFN-gamma responses and protective immunity to challenge with a high virulence T. gondii strain. Our results demonstrate that MyD88 is required to control Toxoplasma infection, but that the parasite can trigger adaptive immunity without the need for this TLR adaptor molecule.